Idera Pharmaceuticals, Inc. (IDRA.W)

IDRA.W on CBOE When Trading NASDAQ Global Select Market

4.65USD
3 Feb 2010
Price Change (% chg)

$0.04 (+0.86%)
Prev Close
$4.65
Open
--
Day's High
$4.77
Day's Low
$4.64
Volume
20,332
Avg. Vol
37,990
52-wk High
$8.50
52-wk Low
$4.48

IDRA.W

Chart for IDRA.W

About

Idera Pharmaceuticals, Inc. (Idera) is a biotechnology company. The Company is engaged in the discovery and development of synthetic deoxyribonucleic acid (DNA)-and ribonucleic acid (RNA)-based drug candidates targeted to Toll-Like Receptors (TLRs), to treat infectious diseases, autoimmune diseases, cancer, and asthma and... (more)

Overall

Beta: 1.66
Market Cap (Mil.): $110.31
Shares Outstanding (Mil.): 23.47
Annual Dividend: 0.00
Yield (%): NA

Financials

  IDRA.W Industry Sector
P/E (TTM): 28.44 11.50 3.76
EPS (TTM): 196.55 -- --
ROI: 11.60 1.25 2.30
ROE: 16.11 2.09 2.82
view overview for:

Competitors

  Price Change
Pfizer Inc. (PFE.N) $17.88 +0.04
Dynavax Technologies Corporation (DVAX.OQ) $1.49 +0.05
Anadys Pharmaceuticals, Inc. (ANDS.OQ) $2.22 +0.01
Cytos Biotechnology AG (CYTN.S) CHF12.50 +0.25
Eisai Co., Ltd (4523.T) ¥3,285.00 -15.00
GlaxoSmithKline plc (GSK.L) £1,207.50 -11.00
Hemispherx BioPharma, Inc (HEB.A) $0.68 0.00
Innate Pharma SA (IPH.PA) €2.04 -0.11
Intercell AG (ICEL.VI) €23.03 -0.15
AstraZeneca plc (AZN.L) £2,827.50 +12.00

  Earnings  vs    Estimates

view overview for: